|
|
|
|
|
 |
|
|

|
| Targeting the Pathophysiology of Type 2 Diabetes: The Emerging Role of Incretin-Based Therapies |
| Include proceedings from a symposium held during the 2008 Cardiometabolic Health Congress in Boston, Massachusetts |
| Activity Date: December 2008 — Activity Info: Volume 8, (11) |
 |
| |
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|